TG Therapeutics - 54 Year Dividend History | TGTX
Historical dividend payout and yield for TG Therapeutics (TGTX) since 1971. The current TTM dividend payout for TG Therapeutics (TGTX) as of January 17, 2025 is $0.00. The current dividend yield for TG Therapeutics as of January 17, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$4.600B |
$0.234B |
|
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
